Ligand Pharmaceuticals
LGND
$70.57
Share price
0.28%
Change (1 day)
-8.66%
Change (1 year)
Ligand Pharmaceuticals (LGND) - P/B ratio
P/B ratio as of April 2024 : 1.79
According to Ligand Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 1.79.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ligand Pharmaceuticals - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.78 | -5.93% |
| 2022-12-31 | 1.89 | -39.92% |
| 2021-12-31 | 3.14 | 39.46% |
| 2020-12-31 | 2.25 | -1.43% |
| 2019-12-31 | 2.29 | -54.48% |
| 2018-12-31 | 5.02 | -27.23% |
| 2017-12-31 | 6.90 | 20.55% |
| 2016-12-31 | 5.73 | -26.69% |
| 2015-12-31 | 7.81 | -81.7% |
| 2014-12-31 | 42.7 | 96.65% |
| 2013-12-31 | 21.7 | 30.23% |
| 2012-12-31 | 16.7 | -41.6% |
| 2011-12-31 | 28.5 | -179.5% |
| 2010-12-31 | -35.9 | -153.08% |
| 2009-12-31 | 67.6 | -369.41% |
| 2008-12-31 | -25.1 | -260.47% |
| 2007-12-31 | 15.6 | -60.73% |
| 2006-12-31 | 39.8 | -639.8% |
| 2005-12-31 | -7.38 | -34.58% |
| 2004-12-31 | -11.3 | -60.61% |
| 2003-12-31 | -28.6 | -652.3% |
| 2002-12-31 | 5.18 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | 186.70% | 🇺🇸 USA |
 Pfizer PFE | 1.61 | -9.84% | 🇺🇸 USA |
 Eli Lilly LLY | 64.1 | 3,489.83% | 🇺🇸 USA |
 Amgen AMGN | 23.2 | 1,201.11% | 🇺🇸 USA |
 Baxter BAX | 2.42 | 35.29% | 🇺🇸 USA |
 Merck MRK | 8.83 | 394.41% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.09 | 72.76% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.16 | 189.19% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | 7.89 | 341.61% | 🇺🇸 USA |